|
Appointed to the Board effective December 2006. Since July 2005 Dr. Dunsire has been the President and Chief Executive Officer of Millennium Pharmaceuticals Inc. an oncology and inflammation-focused biopharmaceutical company based in Cambridge Massachusetts. Prior to joining Millennium Pharmaceuticals Dr. Dunsire led the Novartis U.S. Oncology Business playing a critical role in the broad development and successful launch of a number of products. Dr. Dunsire was also responsible for managing the merger and significant growth of the combined Sandoz Pharmaceuticals and Ciba-Geigy oncology businesses. Dr. Dunsire served on the U.S. pharmaceutical Executive Committee at Novartis and was a member of the operating committee charged with defining corporate strategy managing operations and assessing executive performance. Dr. Dunsire is currently a board member of the Pharmaceutical Research and Manufacturers of America (PhRMA).
| 